DNMT1 and ductal breast carcinoma in situ: In summary, this study demonstrates that miR‐217 acts as a critical regulatory factor in the biology of DCIS cells by targeting DNMT1, inhibiting methylation of the TSHZ2 promoter region, and suppressing the Hedgehog‐GLI signaling pathway.